KEGG   DRUG: D04612Help
Entry
D04612                      Drug                                   

Name
Iratumumab (USAN)
Activity
Oncological diseases;
Treatment of relapsed or refractory CD30 positive lymphoma including Hodgkin's disease
Comment
Monoclonal antibody
Target
CD30 [HSA:943] [KO:K05145]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction  
 
Brite
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  TNF receptor family
   TNFRSF8 (CD30)
    Iratumumab
     D04612  Iratumumab (USAN)
BRITE hierarchy
Other DBs
CAS: 
640735-09-7
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system